Sumaxin CP NDC 43538-101

NDC codes

FDA NDC Directory

Product NDC (as listed)43538-101Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43538-0101Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43538-101-60	43538010160	1 KIT in 1 CARTON (43538-101-60) * 60 PACKET in 1 CARTON / 3.7 g in 1 PACKET * 1 BOTTLE, PUMP in 1 CARTON / 454 g in 1 BOTTLE, PUMPMarketed from Aug 1, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sumaxin CP
Generic name (nonproprietary): sulfacetamide sodium and sulfur
Dosage form: Kit
Labeler: Medimetriks Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Aug 1, 2011
Listing expires: Dec 31, 2026
Identifiers: Product ID 43538-101_10983826-2970-4ff2-87f6-6633c093843fSPL ID 10983826-2970-4ff2-87f6-6633c093843fSPL set ID 5d9ddc1a-fbae-4595-86ce-3bbca7d03482RxCUI 1000946, 1000976UNII 4NRT660KJQ, 70FD1KFU70

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N443538010160 followed by a unit qualifier and the quantity

Package 43538-0101-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 15, 2023.

Indications (excerpt from the label)

INDICATIONS Sumaxin ® (sodium sulfacetamide 10% & sulfur 4%) Cleansing Pads are indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)